Old mice present increased levels of succinate dehydrogenase activity and lower vulnerability to dyskinetic effects of 3-nitropropionic acid

Pharmacology Biochemistry and Behavior

Volumn 91, Issue 3, 2009, Pages 327-332

  Rosenstock, T R ^a   Abilio V C ^a   Frussa Filho, R ^a   Kiyomoto, B H ^a   Smaili, S S ^a  

^a FEDERAL UNIVERSITY OF SÃO PAULO   (Brazil)

Author keywords

3 Nitropropionic acid; Aging; Huntington's disease; Orofacial dyskinesia; Oxidative stress; Succinate dehydrogenase

Indexed keywords

3 NITROPROPIONIC ACID; SUCCINATE DEHYDROGENASE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; ENZYME ACTIVITY; ENZYME INDUCTION; ENZYME INHIBITION; HISTOCHEMISTRY; HUNTINGTON CHOREA; MALE; MOUSE; NONHUMAN; OROFACIAL DYSKINESIA; OXIDATIVE STRESS; PRIORITY JOURNAL;

AGING; ANIMALS; BRAIN; DYSKINESIA, DRUG-INDUCED; IMMUNOHISTOCHEMISTRY; MALE; MICE; MICE, INBRED CBA; NITRO COMPOUNDS; OXIDATIVE STRESS; PROPIONIC ACIDS; SUCCINATE DEHYDROGENASE;

MUS;

EID: 57449108306     PISSN: 00913057     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.pbb.2008.08.011     Document Type: Article

References (100)

1. Abílio V.C., Vera Jr. J.A., Ferreira L.S., Duarte C.R., Carvalho R.C., Grassl C., et al. Effects of melatonin on orofacial movements in rats. Psychopharmacology (Berl) 161 4 (2002) 340-347
2. Abílio V.C., Araújo C.C.S., Bergamo M., Calvacante P.R.V., D'Almeida V., Ribeiro R de A., et al. Vitamin E attenuates reserpine-induced oral dyskinesia and striatal oxidized glutathione/reduced glutathione ratio (GSSG/GSH) enhancement in rats. Prog Neuropsychopharmacol Biol Psychiatry 27 (2003) 109-114
3. Abílio V.C., Silva R.H., Carvalho R.C., Grassl C., Calzavara M.B., Registro S., et al. Important role of striatal catalase in aging- and reserpine-induced oral dyskinesia. Neuropharmacology 47 2 (2004) 263-272
4. Alexi T., Hughes P.E., Knüsel B., and Tobin A.J. Metabolic compromise with systemic 3-nitropropionic acid produces striatal apoptosis in Sprague-Dawley rats but not in BALBc/cByJ mice. Exp Neurol 153 (1998) 74-93
5. Andreassen O.A., and Jorgensen H.A. The mitochondrial toxin 3-nitropropionic acid induces vacuous chewing movements in rats. Implications for the tardive dyskinesia?. Psychopharmacology (Berl) 119 (1995) 474-476
6. Andreassen O.A., Ferrante R.J., Aamo T.O., Beal M.F., and Jorgensen H.A. Oral dyskinesias and histopathological alterations in substantia nigra after long-term haloperidol treatment of old rats. Neuroscience 122 (2003) 717-725
7. Barbeau A., Duvousin R.C., Gerstenbrand F., Lakke J.P., Marsden C.D., and Stern G. Classification of extrapyramidal disorders. Proposal for an international classification and glossary of terms. J Neurol Sci 51 (1981) 313-327
8. Barja G. Free radicals and aging. Trends Neurosci 27 10 (2004) 595-600
9. Battaglia G., Farrace M.G., Mastroberardino P.G., Viti I., Fimia G.G., Beeumen J.V., et al. Transglutaminase 2 ablation leads to defective function of mitochondrial respiratory complex I affecting neuronal vulnerability in experimental models of extrapyramidal disorders. J Neurochem 100 1 (2007) 36-49
10. Beal M.F. Aging, energy, and oxidative stress in neurodegenerative diseases. Ann Neurol 38 (1995) 357-366
11. Beal M.F. Mitochondrial dysfunction in neurodegenerative diseases. Biochim Biophys Acta 1366 (1998) 211-223
12. Beal M.F., Brouillet E., Jenkins B.G., Ferrante R.J., Kowall N.W., Miller J.M., et al. Neurochemical and histologic characterization of striatal excitotoxic lesions produced by the mitochondrial toxin 3-nitropropionic acid. J Neurosci 13 (1993) 4181-4192
13. Beckman K.B., and Ames B.N. The free radical theory of aging matures. Physiol Rev 78 (1998) 547-581
14. Bergamo M., Abílio V.C., Queiroz C.M., Barbosa-Júnior H.N., Abdanur L.R., and Frussa-Filho R. Effects of age on a new animal model of tardive dyskinesia. Neurobiol Aging 18 6 (1997) 623-629
15. Blum D., Galas M.C., Cuvelier L., and Schiffmann S.N. Chronic intoxication with 3-nitropropionic acid in rats induces the loss of striatal dopamine terminals without affecting nigral cell viability. Neurosci Lett 354 3 (2004) 234-238
16. Bossi S.R., Simpson J.R., and Isacson O. Age dependence of striatal neuronal death caused by mitochondrial dysfunction. Neuroreport 4 (1993) 73-76
17. Boveris A., and Chance B. The mitochondrial generation of hydrogen peroxide. General properties and effect of hyperbaric oxygen. Biochem J 134 (1973) 707-716
18. Brouillet E., Jenkins B.G., Hyman B.T., Ferrante R.J., Kowall N.W., Srivastava R., et al. Age-dependent vulnerability of the striatum to the mitochondrial toxin 3-nitropropioni acid. J Neurochem 60 (1993) 356-359
19. Brouillet E., Guyot M.C., Mittoux V., Altairac S., Conde F., Palfi S., et al. Partial inhibition of brain succinate dehydrogenase by 3-nitropropionic acid is sufficient to initiate striatal degeneration in rat. J Neurochem 70 2 (1998) 794-805
20. Brouillet E., Condé F., Beal M.F., and Hantraye P. Replicating Huntington's disease phenotype in experimental animals. Prog Neurobiol 59 (1999) 427-468
21. Brouillet E., Menetrat H., Ouary S., Altairac S., Poyot T., Mittoux V., et al. Major species difference in behaviour and neuropathological deficit observed in rats following chronic 3-nitropropionate treatment: implication for modeling Huntington's disease in rodents. Neuroscience 97 3 (2000) 521-530
22. Browne S.E., Ferrante R.J., and Beal M.F. Oxidative stress in Huntington's disease. Brain Pathol 9 (1999) 147-163
23. Brustovetsky N., LaFrance R., Purl K.J., Brustovetsky T., Keene C.D., Low W.C., et al. Age-dependent changes in the calcium sensitivity of striatal mitochondria in mouse models of Huntington's Disease. J Neurochem 93 6 (2005) 1361-1370
24. Burger M., Fachinetto R., Calegari L., Paixão M.W., Braga A.L., and Rocha J.B. Effects of age on reserpine-induced orofacial dyskinesia and possible protection of diphenyl diselenide. Brain Res Bull 64 4 (2004) 339-345
25. Burger M., Fachinetto R., Calegaria L., Paixão M.W., Braga A.L., and Rocha J.B.T. Effects of age on reserpine-induced orofacial dyskinesia and possible protection of diphenyl diselenide. Brain Res Bull 64 (2004) 339-345
26. Burger M., Fachinetto R., Zeni G., and Rocha J.B. Ebselen attenuates haloperidol-induced orofacial dyskinesia and oxidative stress in rat brain. Pharmacol Biochem Behav 81 3 (2005) 608-615
27. Bywood P.T., and Johnson S.M. Mitochondrial complex inhibitors preferentially damage substantia nigra dopamine neurons in rat brain slices. Exp Neurol 179 1 (2003) 47-59
28. Cadenas E., and Davies K.J.A. Mitochondrial free radical generation, oxidative stress, and aging. Free Radic Biol Med 29 (2000) 222-230
29. Calvente P.R.V., Araújo C.C.S., Bergamo M., Abílio V.C., D'Almeida V., Ribeiro R de A., et al. The mitochondrial toxin 3-nitropropionic acid aggravates reserpine-induced oral dyskinesia in rats. Prog Neuropsychopharmacol Biol Psychiatry 26 (2002) 1-5
30. Casey D.E. Tardive dyskinesia: pathophysiology and animal models. J Clin Psych 61 (2000) 5-9
31. Colpo G., Trevisol F., Teixeira A.M., Fachinetto R., Pereira R.P., Athayde M.L., et al. Ilex paraguariensis has antioxidant potential and attenuates haloperidol-induced orofacial dyskinesia and memory dysfunction in rats. Neurotox Res 12 (2007) 171-180
32. Coyle J.T., and Puttfarcken P. Oxidative stress, glutamate and neurodegenerative disorders. Science 262 (1993) 689-695
33. Droge W. Free radicals in the physiological control of cell function. Physiol Rev 82 (2002) 47-95
34. Ellerby H.M., Martin S.J., Ellerby L.M., Naim S.S., Rabizadeh S., Salvesen G.S., et al. Establishment of cell-free system at neuronal apoptosis: comparison of premitochondrial, mitochondrial, and postmitochondrial phases. J Neurosci 17 (1997) 6165-6178
35. Fachinetto R., Burger M.E., Wagner C., Wondracek D.C., Brito V.B., Nogueira C.W., et al. High fat diet increases the incidence of orofacial dyskinesia and oxidative stress in specific brain regions of rats. Pharmacol Biochem Behav 81 (2005) 585-592
36. Faria R.R., Abílio V.C., Grassl C., Chinen C.C., Negrao L.T., de Castro J.P., et al. Beneficial effects of vitamin C and vitamin E on reserpine-induced oral dyskinesia in rats: critical role of striatal catalase activity. Neuropharmacology 48 7 (2005) 993-1001
37. Ferreira J., and Rocha J.B. High fat diet increases the incidence of orofacial dyskinesia and oxidative stress in specific brain regions of rats. Pharmacol Biochem Behav 81 3 (2005) 585-592
38. Galas M.C., Bizat N., Cuvelier L., Bantubungi K., Brouillet E., Schiffmann S.N., et al. Death of cortical and striatal neurons induced by mitochondrial defect involves differential molecular mechanisms. Neurobiol Dis 15 (2004) 152-159
39. Genova M.L., Pich M.M., Bernacchia A., Bianchi C., Biondi A., Bovina C., et al. The mitochondrial production of reactive oxygen species in relation to aging and pathology. Ann N Y Acad Sci 1011 (2004) 86-100
40. Gu M., Gash M.T., Mann V.M., Javoyagid F., Cooper J.M., and Schapira A.H. Mitochondrial defect in Huntington's disease caudate nucleus. Ann Neurol 39 (1996) 385-389
41. Guyot M.C., Hantraye P., Dolan R., Palfi S., Maziere M., and Brouillet E. Quantifiable bradykinesia, gait abnormalities and Huntington's disease-like striatal lesions in rats chronically treated with 3-nitropropionic acid. Neuroscience 79 (1997) 45-56
42. Haripriya D., Devi M.A., Kokilavani V., Sangeetha P., and Panneerselvam C. Age-dependent alterations in mitochondrial enzymes in cortex, striatum and hippocampus of rat brain - potential role of l-carnitine. Biogerontology 5 5 (2004) 355-364
43. Harman D. Free radical theory of aging: increasing the average life expectancy at birth and the maximum life span. J Anti Aging Med 2 (1999) 199-208
44. Hensley K., and Floyd R.A. Reactive oxygen species and protein oxidation in aging: a look back, a look ahead. Arch Biochem Biophys 397 (2002) 377-383
45. Herbst A., Pak J.W., McKenzie D., Bua E., Bassiouni M., and Aiken J.M. Accumulation of mitochondrial DNA deletion mutations in aged muscle fibers: evidence for a causal role in muscle fiber loss. J Gerontol A Biol Sci Med Sci 62 3 (2007) 235-245
46. Huntington Disease Collaborative Research Group. A novel gene containing a trinucleotide repeat that is expanded and unstable on Huntington's disease chromosomes. Cell 72 (1993) 971-983
47. Jakel R.J., and Maragos W.F. Neuronal cell death in Huntington's disease: a potential role for dopamine. Trends in Neurosci 23 (2000) 239-245
48. Johansson P., Casey D.E., and Gunne L.M. Dose-dependent increases in rat spontaneous chewing rats during long-term administration of haloperidol but not clozapine. Psychopharmacol Bull 22 (1986) 1017-1019
49. Khunderyakova N.V., Zakharchenko M.V., Zakharchenko A.V., and Kondrashova M.N. Hyperactivation of succinate dehydrogenase in lymphocytes of newborn rats. Biochemistry (Mosc) 73 3 (2008) 337-341
50. Kim G.W., and Chan P.H. Oxidative stress and neuronal DNA fragmentation mediate age-dependent vulnerability to the mitochondrial toxin, 3-nitropropionic acid, in the mouse striatum. Neurobiol Dis 8 (2001) 114-126
51. Kiyomoto B.H., Tengan C.H., and Godinho R.O. Effects of short-term zidovudine exposure on mitochondrial DNA content and succinato dehydrogenase activity of rat skeletal muscle cells. J Neurol Sci 268 (2008) 33-39
52. Kroemer G. The proto-oncogene Bcl-2 and its role in regulating apoptosis. Nat Med 3 (1997) 614-620
53. Kumar P., Padi S.S., Naidu O.S., and Kumar A. Effect of resveratrol on 3-nitropropionic acid-induced biochemical and behavioral changes: possible neuroprotective mechanisms. Behav Pharmacol 17 5-6 (2006) 485-492
54. Kwong L.K., and Sohal R.S. Age-related changes in activities of mitochondrial electron transport complex in various tissues of the mouse. Arch Biochem Biophys 373 1 (2000) 16-22
55. Lee H., and Wei Y. Mitochondrial alterations, cellular response to oxidative stress and defective degradation of proteins in aging. Biogerontology 2 (2001) 231-244
56. Levine R.L., and Stadtman E.R. Oxidative modification of proteins during aging. Exp Gerontol 36 (2001) 1495-1502
57. Lohr J.B., Kuczenski R., and Niculescu A.B. Oxidative mechanisms and tardive dyskinesia. CNS Drugs 17 (2003) 47-62
58. 2+ stores and contractile response of intestinal smooth muscle. Exp Gerontol 41 1 (2006) 55-62
59. Lopes G.S., Mora O.A., Cerri P., Faria F.P., Jurkiewicz N.H., Jurkiewicz A., et al. Mitochondrial alterations and apoptosis in smooth muscle from aged rats. Biochim Biophys Acta 1658 3 (2004) 187-194
60. Ludolph A.C., Seeling M., Ludolph A., Novitt P., Allen C.N., Spencer P.S., et al. 3-nitropropionic acid decreases cellular energy levels and causes neurodegeneration in cortical explants. Neurodegeneration 1 (1992) 155-161
61. Manczak M., Jung Y., Park B.S., Partovi D., and Reddy P.H. Time-course of mitochondrial gene expressions in mice brains: implications for mitochondrial dysfunction, oxidative damage, and cytochrome c in aging. J Neurochem 92 3 (2005) 494-504
62. Mattson M.P. Apoptosis in neurodegenerative disorders. Nat Rev Mol Cell Biol 1 2 (2000) 120-129
63. Meccocci P., MacGArvey U., and Beal M.F. Oxidative damage to mitochondrial DNA is increased in Alzheimer's disease. Ann Neurol 36 (1994) 747-751
64. Miquel J., Economos A.C., Fleming J., and Johnson Jr. J.E. Mitochondrial role in cell aging. Exp Gerontol 15 (1980) 575-591
65. Naidu P.S., Singh A., and Kulkarni S.K. Carvedilol attenuates neuroleptic-induced orofacial dyskinesia: possible antioxidant mechanisms. Br J Pharmacol 136 2 (2002) 193-200
66. Naidu P.S., Singh A., and Kulkarni S.K. Quercetin, a bioflavonoid, attenuates haloperidol-induced orofacial dyskinesia. Neuropharmacology 44 8 (2003) 1100-1106
67. Naidu P.S., Singh A., and Kulkarni S.K. Effect of Withania somnifera root extract on reserpine-induced orofacial dyskinesia and cognitive dysfunction. Phytother Res 20 (2006) 140-146
68. Napolitano M., Centonze D., Gubellini P., Rossi S., Spiezia S., Bernardi G., et al. Inhibition of mitochondrial complex II alters striatal expression of genes involved in glutamatergic and dopaminergic signaling: possible implications for Huntington's disease. Neurobiol Dis 15 2 (2004) 407-414
69. Navarro A., and Boveris A. Rat brain and liver mitochondria develop oxidative stress and lose enzymatic activities on aging. Am J Physiol Regul Integr Comp Physiol 287 5 (2004) R1244-1249
70. Nicholls D.G. Mitochondrial function and dysfunction in the cell: its relevance to aging and aging-related disease. Int J Biochem Cell Biol 34 (2002) 1372-1381
71. Nishino H., Shimano Y., Kumazaki M., and Sakurai T. Chronically administered 3-nitropropionic acid induces striatal lesion attributed to dysfunction of the blood-brain barrier. Neurosci Lett 186 (1995) 161-164
72. Nishino H., Kumazaki M., Fukuda A., Fujimoto I., Shimano Y., Hida H., et al. Acute 3-nitropropionic acid intoxication induces striatal astrocytic cell death and dysfunction of the blood-brain barrier: involvement of dopamine toxicity. Neurosci Res 27 (1997) 343-355
73. Olgun A., and Akman S. Mitochondrial DNA-deficient models and aging. Ann N Y Acad Sci 1100 (2007) 241-245
74. Ouary S., Bizat N., Altairac S., Menetrat H., Mittoux V., Conde F., et al. Major strain differences in response to chronic systemic administration of the mitochondrial toxin 3-nitropropionic acid in rats: implications for neuroprotection studies. Neuroscience 97 3 (2000) 521-530
75. Ozawa T. Genetic and functional changes in mitochondria associated with aging. Physiol Rev 77 (1997) 425-464
76. Palfi S., Ferrante R.J., Brouillet E., Beal M.F., Dolan R., Guyot M.C., et al. Chronic 3-nitropropionic acid treatment in baboons replicates the cognitive and motor deficits of Huntington's disease. J Neurosci 16 (1996) 3019-3025
77. Panov A.V., Gutekunst C.A., Leavitt B.R., Hayden M.R., Burke J.R., Strittmatter W.J., et al. Early mitochondrial calcium defects in Huntington's disease are a direct effect of polyglutamines. Nat Neurosci 5 (2002) 731-736
78. Petersén A., Mani K., and Brundin P. Recent advances on the pathogenesis of Huntington's disease. Exp Neurol 157 (1999) 1-18
79. Rebrin I., and Sohal R.S. Comparison of thiol redox state of mitochondria and homogenates of various tissues between two strains of mice with different longevities. Exp Gerontol 39 (2004) 1513-1519
80. Reddy P.H., McWeeney S., Manczak M., Park B.S., Gutala R.V., Jung Y., et al. Gene expression profiles of transcripts in amyloid precursor protein transgenic mice: upregulation of mitochondrial metabolism and apoptotic genes is an early cellular change in Alzheimer's disease. Hum Mol Genet 13 (2004) 1225-1240
81. Reiter R.J. Oxidative damage in the central nervous system: protection by melatonin. Prog Neurobiol 56 (1998) 359-384
82. Reynolds D.S., Carter R.J., and Morton A.J. Dopamine modulates the susceptibility of striatal neurons to 3-nitropropionic acid in the rat model of Huntington's disease. J Neurosci 18 (1998) 10116-10127
83. Rosenstock T.R., Carvalho A.C.P., Jurkiewicz A., Frussa-Filho R., and Smaili S.S. Mitochondrial calcium, oxidative stress and apoptosis in a neurodegenerative disease model induced by 3-nitropropionic acid. J Neurochem 88 (2004) 1220-1228
84. Rupniak N.M.J., Mann S., Hall M.D., Fleminger S., Kilpatrick G., Jenner P., et al. Differential effects of continuous administration for 1 year of haloperidol or sulpiride on striatal dopamine function in the rat. Psychopharmacology (Berlin) 84 (1984) 503-511
85. Samokhvalov V., Ignatov V., and Kondrashova M. Inhibition of Krebs cycle and activation of glyoxylate cycle in the course of chronological aging of Saccharomyces cerevisiae. Compensatory role of succinate oxidation. Biochimie 86 1 (2004) 39-46
86. Sato T., and Tauchi H. Age changes of mitochondria of rat kidney. Mech Ageing Dev 20 (1982) 111-126
87. Schagger H. Respiratory chain supercomplexes of mitochondria and bacteria. Biochim Biophys Acta 1555 (2002) 154-159
88. Seligman A.M., and Rutenburg A.M. The histochemical demonstration of succinic dehydrogenase. Science 113 2934 (1951) 317-320
89. Sohal R.S., Mockett R.J., and Orr W.C. Mechanisms of aging: an appraisal of the oxidative stress hypothesis. Free Radic Biol Med 33 (2002) 575-586
90. Szibor M., and Holtz J. Mitochondrial ageing. Basic Res Cardiol 98 4 (2003) 210-218
91. Tanji K., and Bonilla R. Optical imaging techniques (histochemical, immunohistochemical, and in situ hybridization staining methods) to visualize mitochondria. Methods Cell Biol 65 (2001) 311-332
92. 2+ and mitochondria as substrates for deficits in synaptic plasticity in normal brain ageing. J Cell Mol Med 8 2 (2004) 181-190
93. Toescu E.C., Myronova N., and Verkhratsky A. Age-related structural and functional changes of brain mitochondria. Cell Calcium 28 (2000) 329-338
94. Turrens J.F. Superoxide production by the mitochondrial respiratory chain. Biosci Rep 17 (1997) 3-8
95. Vasin M.V., Ushakov I.B., Koroleva L.V., Lairov I.A., and Radchenko S.N. In vitro response of mitochondrial succinate oxidase system to epinephrine in human blood lymphocytes from health individuals and patients with neurocirculatory dystonia. Bull Exp Biol Med 134 4 (2002) 393-396
96. Vonsattel J.P., and DiFiglia M. Huntington disease. J Neuropathol Exp Neurol 57 (1998) 369-384
97. Waddington J.L. Spontaneous orofacial movements induced by very long-term neuroleptic drug administration: phenonomenology, pathophysiology and putative relationship to tardive dyskinesia. Psychopharmacology 101 (1990) 431-447
98. Waddington J.L., Youssef H.A., Molloy A.G., O'Boyle K.M., and Pugh M.T. Association of intellectual impairment, negative symptoms and aging with abnormal, involuntary movements (tardive dyskinesia) in schizophrenia: clinical and animal studies. J Clin Psychiatry 46 (1985) 29-33
99. Wickens A.P. Ageing and free radical theory. Respir Physiol 128 (2001) 379-391
100. Zamzami N., Marzo I., Susin S.A., Brenne C., Larochette N., Marchetti P., et al. The thiol crosslinking agent diamide overcomes the apoptosis-inhibitory effect of Bcl-2 by enforcing mitochondrial permeability transition. Oncogene 16 (1998) 1055-1063